Federal award
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
W81XWH2220044
Assistance
Obligated and Ceiling
- Obligated (net)
- $850,776.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $850,776.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- LOVELACE BIOMEDICAL RESEARCH INSTITUTE · MBT9RXJJ7428
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- LOVELACE BIOMEDICAL RESEARCH INSTITUTE · MBT9RXJJ7428
- Awarding agency
- Department of Defense · sub-agency 97DH · office HT9425
- Funding agency
- Department of Defense · sub-agency 97DH
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH2220044
- Award type code
- 05
- Actions
- 4 · Aug 8, 2022 to Feb 4, 2026
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 4, 2026 | FY2026 | P00003 | B1 | $0.00 | — |
| Oct 4, 2024 | FY2025 | P00002 | B1 | $0.00 | — |
| Dec 5, 2022 | FY2023 | P00001 | EX | $222,662.43 | — |
| Aug 8, 2022 | FY2022 | 0 | A1 | $628,113.57 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.